Event
KKR Launches Stellar Renewable Power

KKR Launches Stellar Renewable Power

New platform to originate long-duration, high yielding solar energy investments through greenfield development and acquisitions NEW YORK--(BUSINESS WIRE)-- KKR, a leading global investment firm, today announced the launch of Stellar Renewable Power (“Stellar”), a new

Politics
Permira in USD 5.8bn Mimecast take-private

Permira in USD 5.8bn Mimecast take-private

Permira is to acquire UK-headquartered cybersecurity software Mimecast in a USD 5.8bn take-private deal, the company announced in a statement on 7 December.

Pharma and Healthcare
Triton to buy Clinigen in GBP 1.2bn deal

Triton to buy Clinigen in GBP 1.2bn deal

Triton has made a GBP 1.2bn take-private offer for UK-based listed pharmaceutical services and products provider Clinigen; the company's board has agreed to the offer, according to a statement.

Quilvest Capital buys into Southern California urgent care clinic chain UrgentMED

Quilvest Capital Partners has made a substantial growth investment in UrgentMED, a network of urgent care clinics in Southern California. The post Quilvest Capital buys into Southern California urgent care clinic chain UrgentMED first appeared

JF Lehman buys Narda-MITEQ from defence specialist L3Harris Technologies

Private equity house JF Lehman & Co has bought the Narda-MITEQ division and the stock of Narda Safety Test Solutions from L3Harris Technologies. The post JF Lehman buys Narda-MITEQ from defence specialist L3Harris Technologies first

OrbiMed promoted Matthew Rizzo, Peter Thompson as general partners

Healthcare investor OrbiMed has promoted Matthew Rizzo and Peter Thompson as general partners. The post OrbiMed promoted Matthew Rizzo, Peter Thompson as general partners first appeared on AltAssets Private Equity News.

Triton to take UK pharmaceutical firm Clinigen private in a £1.2bn deal

European private equity house Triton has agreed a £1.2bn take private deal with UK pharmaceutical firm Clinigen. The post Triton to take UK pharmaceutical firm Clinigen private in a £1.2bn deal first appeared on AltAssets

Kainos sells kids’ drink business good2grow to Wind Point after expanding product range

Food and consumer-focused private equity house Kainos Capital has sold kids' drinks company good2grow to Wind Point Partners. The post Kainos sells kids’ drink business good2grow to Wind Point after expanding product range first appeared

Israel’s Lool Ventures races towards Fund III goal through $60m first close

Israel-based seed invstor Lool Ventures has hit a $60m first close for its third fundraise, putting it well on the way to its goal. The post Israel’s Lool Ventures races towards Fund III goal through

Appointments
Felix hires two new partners

Felix hires two new partners

Felix Capital has appointed two new partners, promoting Susan Lin and hiring Julien Codorniou from Facebook.

Politics
Inflexion taps Harris Williams for upcoming Alcumus exit

Inflexion taps Harris Williams for upcoming Alcumus exit

Inflexion is preparing to exit UK-based certification and software provider Alcumus in a process slated for next year, according to three sources familiar with the situation.

Software and Hi-Tech
Asmodee draws Carlyle, Embracer Group in final stages

Asmodee draws Carlyle, Embracer Group in final stages

Private equity firm Carlyle Group and Swedish gaming business Embracer Group have reached the second round of bidding for French gaming publisher and distributor Asmodee, according to four sources familiar with the matter.

CDPQ takes stake in supply chain testing, inspection business QIMA

Institutional investment major Caisse de dépôt et placement du Québec has picked up a significant minority interest in QIMA, a provider of supply chain compliance solutions. The post CDPQ takes stake in supply chain testing,

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.